The Health Department has defended its R15.5bn AIDS drug tender against a legal challenge from pharmaceutical manufacturer Cipla. The department argues that officials followed a fair and rational process when awarding contracts to supply key HIV medicines. The dispute centres on contracts that took effect on 1 December 2025. They cover the daily treatment used by most HIV patients. Cipla,…